disease 1,460 words KG: ent-dise-32f7d39d
Contents

Mirror Therapy and Sensory Re-education in Corticobasal Syndrome

Disease Info
Motor cortex activationVisual observation of movement activates motor cortex regions corresponding to the observed action
Premotor and supplementary motor areasMirror therapy engages planning and preparation networks
Inferior parietal lobuleIntegration of visual and proprioceptive information for body schema maintenance
Superior temporal sulcusAction recognition and movement interpretation
Cortical reorganizationUndamaged cortical regions can assume function of damaged areas
Cross-modal plasticityVisual input can substitute for diminished somatosensory input
Use-dependent plasticityRepetitive, task-specific practice drives cortical reorganization
Attention-dependent plasticityFocused attention enhances learning and cortical change
Dorsal visual pathwayProcessing spatial and visual-tactile integration
Somatosensory cortexReorganization of cortical representation maps
Posterior parietal cortexBody schema and spatial representation
Thalamic relaysMaintaining sensory transmission while cortical areas recover
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (25)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Purinergic Signaling Polarization Control
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.95
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
CYP46A1 Overexpression Gene Therapy
Score: 0.77
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69
pg 1/2Next →

Related Analyses (20)

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (1)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40

See Also (15)

Metabolomic Biomarkers in Neurodegeneration
biomarker · Pages share 4 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 4 hypotheses
Blood-Based Biomarkers for Neurodegeneration
biomarker · Pages share 4 hypotheses
MDS 2026 — Fluid Biomarker Advances in Neurodegeneratio
event · Pages share 4 hypotheses
Neuroimaging Biomarkers for Neurodegeneration
biomarker · Pages share 4 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.